Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Triglide, Fenofibrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

96 API Suppliers, 26 USDMF, 16 CEP/COS, 3 JDMF, 14 EU WC, 28 KDMF, 17 NDC API, 46 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

314 FDF Dossiers, 131 FDA Orange Book, 65 Europe, 12 Canada, 34 Australia, 3 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG, CAPSULE;ORAL - 150MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - 145MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 48MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 130MG, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 43MG, CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 105MG, TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 14 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Kewpie Corporation, 14 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 15 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 53 Solubilizers, 52 Thickeners and Stabilizers, 51 Coating Systems & Additives, 49 Direct Compression, 48 Disintegrants & Superdisintegrants, 40 Granulation, 31 Taste Masking, 31 Controlled & Modified Release, 30 Topical, 26 Lubricants & Glidants, 23 Parenteral, 22 Chewable & Orodispersible Aids, 22 Film Formers & Plasticizers, 18 Emulsifying Agents, 16 Co-Processed Excipients, 11 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 61 News #PharmaBuzz

GLOBAL SALES INFORMATION

61 US Medicaid Prescriptions, 39 Regulatory FDF Prices

MARKET PLACE

25 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22418 / DOSAGE - TABLET;ORAL - 105MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Fenofibric Acid(UNII: BGF9MN2HU1) (Fenofibric Acid - UNII:BGF9MN2HU1)	Fenofibric Acid	35mg \| 105mg

Inactive Ingredients

Ingredient Name	Caraco Pharma, Inc.	Mutual Pharmaceutical Company, Inc.
cellulose, microcrystalline(OP1R32D61U)
Copovidone K25-31(D9C330MD8B)
crospovidone(68401960MK)
magnesium stearate(70097M6I30)

Drug Product Composition: Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Triglide, Fenofibrate